Literature DB >> 31842679

MOG-antibody-associated disease is different from MS and NMO and should be considered as a distinct disease entity - No.

Alvaro Cobo-Calvo1, Romain Marignier1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31842679     DOI: 10.1177/1352458519863135

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


× No keyword cloud information.
  1 in total

1.  Relapse activity in the chronic phase of anti-myelin-oligodendrocyte glycoprotein antibody-associated disease.

Authors:  Tetsuya Akaishi; Tatsuro Misu; Kazuo Fujihara; Toshiyuki Takahashi; Yoshiki Takai; Shuhei Nishiyama; Kimihiko Kaneko; Juichi Fujimori; Tadashi Ishii; Masashi Aoki; Ichiro Nakashima
Journal:  J Neurol       Date:  2021-11-25       Impact factor: 6.682

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.